Spots Global Cancer Trial Database for genetic testing
Every month we try and update this database with for genetic testing cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program | NCT01772771 | Glioma Hematopoietic a... Malignant Solid... Melanoma Sarcoma | Biospecimen Col... Genetic Testing Medical Chart R... | - | M.D. Anderson Cancer Center | |
| Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland | NCT03124212 | Hereditary Brea... Lynch Syndrome | CASCADE genetic... | 18 Years - | University of Basel | |
| Community-Based Health Coach to Improve Access to Germline Genetic Testing Among African American Men With Prostate Cancer | NCT04763980 | Prostate Carcin... | Educational Int... Genetic Testing Survey Administ... | 18 Years - | University of California, San Francisco | |
| Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics Tests | NCT03889171 | Cancer Colorectal Canc... Breast Cancer Ovarian Cancer | Behaviour | 18 Years - | University Hospital, Montpellier | |
| Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility | NCT02133703 | Breast Cancer Ovarian Cancer | Enhanced Intern... Internet DA Enhanced Print ... Print DA Inconclusive Re... | 21 Years - 75 Years | Georgetown University | |
| Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial | NCT03765736 | Metastatic Colo... Metastatic Rect... Stage III Colon... Stage III Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IV Colon ... Stage IV Rectal... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... Stage IVC Colon... Stage IVC Recta... Unresectable Co... Unresectable Re... | Genetic Testing | 18 Years - | Academic and Community Cancer Research United | |
| Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care | NCT03460483 | Endometrial Ade... Endometrial Car... Lynch Syndrome Relatives | Genetic Counsel... Genetic Testing Laboratory Biom... Mutation Carrie... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Choices About Genetic Testing And Learning Your Risk With Smart Technology | NCT06184867 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... Breast Cancer Pancreas Cancer Colorectal Canc... Endometrial Can... Prostate Cancer | Relational Agen... Clinical Letter | 18 Years - | Rutgers, The State University of New Jersey | |
| Cancer Genetic Testing in Ethnic Populations | NCT04475640 | Breast Carcinom... Carcinoma of Un... Central Nervous... Digestive Syste... Genitourinary S... Head and Neck C... Malignant Brain... Malignant Femal... Malignant Muscu... Malignant Solid... Skin Carcinoma | Biospecimen Col... Genetic Testing | 18 Years - | Mayo Clinic | |
| Adherence to Intensive Surveillance for Hereditary Breast Cancer | NCT00582803 | Breast Cancer | 25 Years - | Memorial Sloan Kettering Cancer Center | ||
| Methods for Increasing Genetic Testing Uptake in Michigan | NCT05162846 | Breast Cancer Colorectal Canc... Ovarian Cancer Prostate Cancer Pancreatic Canc... Endometrial Can... History of Canc... | Publicly availa... Virtual genetic... Motivational in... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors | NCT02921984 | Salivary Gland ... Head and Neck C... | Docetaxel Intensity-modul... Pemetrexed Cisplatin | 18 Years - 70 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer | NCT03688204 | Breast Cancer R... | 18 Years - | Ambry Genetics | ||
| Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing | NCT05759143 | Genetic Predisp... Genetic Predisp... | Nest Platform | 18 Years - 39 Years | Dana-Farber Cancer Institute | |
| Health-promoting Lifestyle in a Genetic Counseling Clinic | NCT05545254 | Breast Cancer Genetic Testing | genetic testing | 18 Years - | Fudan University | |
| Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care | NCT03460483 | Endometrial Ade... Endometrial Car... Lynch Syndrome Relatives | Genetic Counsel... Genetic Testing Laboratory Biom... Mutation Carrie... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Video Education With Result Dependent dIsclosure | NCT05225428 | Genetic Testing Breast Cancer Ovarian Cancer Pancreatic Canc... Prostate Cancer Colorectal Canc... Renal Cancer Melanoma Sarcoma | Video Education Genetic Counsel... | 18 Years - | Dana-Farber Cancer Institute | |
| Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes | NCT02917798 | Ovarian Cancer Prostate Cancer Pancreas Cancer | Assessments | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer | NCT04354675 | Breast Cancer | Automated progr... Genetics counse... BCGCKQ Survey Satisfaction Su... Genetic testing | 18 Years - | Case Comprehensive Cancer Center | |
| Clinical and Genetic Studies of Li-Fraumeni Syndrome | NCT01443468 | Li-Fraumeni Syn... Neoplasms Tp53 Mutations | - | National Institutes of Health Clinical Center (CC) | ||
| Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer | NCT04354675 | Breast Cancer | Automated progr... Genetics counse... BCGCKQ Survey Satisfaction Su... Genetic testing | 18 Years - | Case Comprehensive Cancer Center | |
| Decision Support for BRCA Testing in Ethnically Diverse Women | NCT03470402 | Breast Cancer BRCA1 Mutation BRCA2 Mutation Ovarian Cancer | RealRisks BNAV iNYP Standard Educat... High-Risk Messa... | 21 Years - 75 Years | Columbia University | |
| Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer | NCT02823652 | Advanced Malign... Locally Advance... | standard geneti... Genetic Counsel... Genetic Testing Internet-Based ... Survey Administ... | 18 Years - | Eastern Cooperative Oncology Group | |
| Choices About Genetic Testing And Learning Your Risk With Smart Technology | NCT06184867 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... Breast Cancer Pancreas Cancer Colorectal Canc... Endometrial Can... Prostate Cancer | Relational Agen... Clinical Letter | 18 Years - | Rutgers, The State University of New Jersey | |
| Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase | NCT06278883 | Cardiovascular ... Cancer Liver Diseases Hyperthermia | Disease Risk As... | 18 Years - | Duke University | |
| Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer | NCT01790516 | Head and Neck S... | Cisplatin cetuximab Radiation | 18 Years - | Georgetown University | |
| INTERogating Cancer for Etiology, Prevention and Therapy Navigation | NCT06008392 | Cancer Cancer Gene Mut... PAN Gene Mutati... | Pan-genomic Tes... | 18 Years - | Mayo Clinic | |
| Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study | NCT04254133 | Prostate Carcin... | Questionnaire Biospecimen Col... Genetic Testing Genetic Counsel... Laboratory Biom... | 35 Years - 89 Years | Fred Hutchinson Cancer Center | |
| A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors | NCT05464875 | Gastrointestina... Unresectable So... Recurrent Metas... | 18 Years - | First Affiliated Hospital, Sun Yat-Sen University | ||
| Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics | NCT03027401 | Neoplasms Adenomatous Pol... Neurofibroma, P... Myelodysplastic... | - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer | NCT02790944 | Pancreatic Duct... | Multi-gene Next... | 18 Years - 89 Years | Ambry Genetics | |
| Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics | NCT03027401 | Neoplasms Adenomatous Pol... Neurofibroma, P... Myelodysplastic... | - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics | NCT03027401 | Neoplasms Adenomatous Pol... Neurofibroma, P... Myelodysplastic... | - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| TSC Biosample Repository and Natural History Database | NCT05676099 | Tuberous Sclero... Lymphangioleiom... | Phlebotomy Buccal (cheek) ... Genetic Testing Tissue donation... | - | National Tuberous Sclerosis Association | |
| A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors | NCT05464875 | Gastrointestina... Unresectable So... Recurrent Metas... | 18 Years - | First Affiliated Hospital, Sun Yat-Sen University | ||
| Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study | NCT04456140 | Breast Carcinom... Digestive Syste... Malignant Brain... Malignant Centr... Malignant Femal... Malignant Genit... Malignant Head ... Malignant Muscu... Malignant Solid... Metastatic Mali... Skin Carcinoma | Biospecimen Col... Genetic Counsel... Genetic Testing Survey Administ... | 18 Years - | Mayo Clinic | |
| Early Detection of GEnetic Risk (EDGE) | NCT04746794 | Genetic Predisp... | Population-leve... | 25 Years - | University of Washington | |
| Choices About Genetic Testing And Learning Your Risk With Smart Technology | NCT06184867 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... Breast Cancer Pancreas Cancer Colorectal Canc... Endometrial Can... Prostate Cancer | Relational Agen... Clinical Letter | 18 Years - | Rutgers, The State University of New Jersey | |
| Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project | NCT03326713 | Breast Cancer Ovarian Cancer | Telephone Couns... Mailed Targeted... Usual Care (UC) | 21 Years - | Rutgers, The State University of New Jersey | |
| Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study | NCT04456140 | Breast Carcinom... Digestive Syste... Malignant Brain... Malignant Centr... Malignant Femal... Malignant Genit... Malignant Head ... Malignant Muscu... Malignant Solid... Metastatic Mali... Skin Carcinoma | Biospecimen Col... Genetic Counsel... Genetic Testing Survey Administ... | 18 Years - | Mayo Clinic | |
| Confronting Cancer as a Community | NCT06063928 | Colorectal Carc... | Archive Sample ... Biospecimen Col... Electronic Heal... Genetic Testing Questionnaire A... | 18 Years - | University of Southern California | |
| Digital Delivery of Information About Genetic Testing for Breast Cancer | NCT04842799 | Breast Neoplasm... | Digital Deliver... Digital Deliver... | 18 Years - | Institute of Cancer Research, United Kingdom | |
| Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study | NCT04254133 | Prostate Carcin... | Questionnaire Biospecimen Col... Genetic Testing Genetic Counsel... Laboratory Biom... | 35 Years - 89 Years | Fred Hutchinson Cancer Center | |
| Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study | NCT04447703 | Biochemically R... Metastatic Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... | Interview Internet Based ... Survey Administ... Genetic Counsel... Genetic Testing Survey Administ... Genetic Counsel... Internet-Based ... Genetic Testing Survey Administ... | 18 Years - | Thomas Jefferson University | |
| Clinical Research of H3F3AK27M in Spinal Glioma and Its Impact on TMZ Chemoradiotherapy | NCT03668522 | Spinal Tumor | Genetic testing | - | Southern Medical University, China | |
| Genetic Testing for All Breast Cancer Patients (GET FACTS) | NCT04245176 | Breast Cancer Invasive Breast... in Situ Breast ... Genetic Testing | Standard Geneti... Quantitative Ge... | 18 Years - 79 Years | Dana-Farber Cancer Institute | |
| Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer | NCT05958082 | Prostate Cancer | Educational vid... | 18 Years - | Henry Ford Health System | |
| Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a | NCT02381015 | Prostate Cancer Prostate Cancer... Hereditary Pros... | Genetic Risk Sc... Genetic Risk Sc... Family History:... Family History:... | 40 Years - 49 Years | NorthShore University HealthSystem | |
| Health-promoting Lifestyle in a Genetic Counseling Clinic | NCT05545254 | Breast Cancer Genetic Testing | genetic testing | 18 Years - | Fudan University | |
| Confronting Cancer as a Community | NCT06063928 | Colorectal Carc... | Archive Sample ... Biospecimen Col... Electronic Heal... Genetic Testing Questionnaire A... | 18 Years - | University of Southern California | |
| Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors | NCT02921984 | Salivary Gland ... Head and Neck C... | Docetaxel Intensity-modul... Pemetrexed Cisplatin | 18 Years - 70 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients | NCT04751435 | Educational Mat... Breast Cancer Ovarian Cancer Prostate Cancer Pancreatic Canc... | Cognitive inter... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) | NCT06340646 | Cholangiocarcin... Multiple Myelom... Colon Cancer Rectal Cancer | Return of Genet... Return of Genet... Return of Genet... | 18 Years - | Washington University School of Medicine | |
| Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study | NCT04456140 | Breast Carcinom... Digestive Syste... Malignant Brain... Malignant Centr... Malignant Femal... Malignant Genit... Malignant Head ... Malignant Muscu... Malignant Solid... Metastatic Mali... Skin Carcinoma | Biospecimen Col... Genetic Counsel... Genetic Testing Survey Administ... | 18 Years - | Mayo Clinic | |
| Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes | NCT04704193 | Genetic Testing | Survey of Decis... | 18 Years - | Massachusetts General Hospital | |
| Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer | NCT03920488 | Triple Negative... | 18 Years - 60 Years | European Institute of Oncology | ||
| Interest and Impact of Skin Cancer Genetic Testing | NCT02941900 | Non-melanoma Sk... | MC1R genotyping MC1R Testing We... Baseline Survey | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Strategic Targeting for Optimal Prevention of Cancer | NCT03897374 | Early Detection... | Genetic Testing | 65 Years - | ClinLogic LLC | |
| Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing | NCT03322176 | Colon Cancer Endometrial Can... | Genetic testing | 18 Years - 64 Years | Data Collection Analysis Business Management | |
| Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer | NCT05877404 | Endometrial Can... | Surveys | - | Wake Forest University Health Sciences | |
| Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition | NCT05721326 | Genetic Predisp... Breast Cancer F... Ovarian Cancer Hereditary Brea... Hereditary Canc... Hereditary Dise... Gene Mutation-R... | Sequential EHR ... | 25 Years - 100 Years | Abramson Cancer Center at Penn Medicine | |
| CBPR - BRCA Genetic Testing Among Orthodox Jews | NCT03624088 | Breast Cancer | RealRisks | 25 Years - | Columbia University | |
| Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes | NCT02917798 | Ovarian Cancer Prostate Cancer Pancreas Cancer | Assessments | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Community-Based Health Coach to Improve Access to Germline Genetic Testing Among African American Men With Prostate Cancer | NCT04763980 | Prostate Carcin... | Educational Int... Genetic Testing Survey Administ... | 18 Years - | University of California, San Francisco | |
| The Genetic Information and Family Testing (GIFT) Study | NCT05552664 | Cancer | GIFT | 18 Years - | University of Michigan Rogel Cancer Center | |
| Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC) | NCT00829959 | Breast Cancer Ovarian Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer | NCT01334021 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Invasive Breast... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... | Biopsy Conventional Su... Genetic Testing | 18 Years - | M.D. Anderson Cancer Center | |
| Validation of a Molecular Prognostic Test for Eye Melanoma | NCT00406120 | Uveal Neoplasms Choroid Neoplas... Iris Neoplasms | Fine needle asp... | - | Washington University School of Medicine | |
| Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot | NCT04002986 | Women Age 35+ Q... | Genetic Testing | 35 Years - | Mayo Clinic | |
| Penn Medicine Biobank Return of Results Program | NCT06089954 | Genetic Disease Cancer Cardiovascular ... | private web-por... eHealth educati... | 18 Years - | University of Pennsylvania | |
| Risk Education and Assessment for Cancer Heredity | NCT01346761 | Breast Cancer Ovarian Cancer Genetic Predisp... | Telephone Genet... In-Person Genet... | 25 Years - 74 Years | University of Utah | |
| Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer | NCT06058377 | Anatomic Stage ... Anatomic Stage ... HER2-Negative B... Hormone Recepto... | Biospecimen Col... Cyclophosphamid... Doxorubicin Durvalumab Genetic Testing Mammography Paclitaxel Quality-of-Life... | 18 Years - | National Cancer Institute (NCI) | |
| Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase | NCT06278883 | Cardiovascular ... Cancer Liver Diseases Hyperthermia | Disease Risk As... | 18 Years - | Duke University | |
| Cancer Genetic Testing in Ethnic Populations | NCT04475640 | Breast Carcinom... Carcinoma of Un... Central Nervous... Digestive Syste... Genitourinary S... Head and Neck C... Malignant Brain... Malignant Femal... Malignant Muscu... Malignant Solid... Skin Carcinoma | Biospecimen Col... Genetic Testing | 18 Years - | Mayo Clinic | |
| Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study | NCT04447703 | Biochemically R... Metastatic Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... | Interview Internet Based ... Survey Administ... Genetic Counsel... Genetic Testing Survey Administ... Genetic Counsel... Internet-Based ... Genetic Testing Survey Administ... | 18 Years - | Thomas Jefferson University | |
| INTERogating Cancer for Etiology, Prevention and Therapy Navigation | NCT06008392 | Cancer Cancer Gene Mut... PAN Gene Mutati... | Pan-genomic Tes... | 18 Years - | Mayo Clinic | |
| Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer | NCT04067960 | Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Biliary Tract C... Clinical Stage ... Clinical Stage ... Malignant Brain... Malignant Genit... Malignant Solid... Pancreatobiliar... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Color... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IIIA Colo... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIB Colo... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Colore... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IVA Color... Stage IVA Ovari... Stage IVA Pancr... Stage IVA Prost... Stage IVB Color... Stage IVB Ovari... Stage IVB Pancr... Stage IVB Prost... Stage IVC Color... | Biospecimen Col... Genetic Testing Quality-of-Life... Questionnaire A... | - | Mayo Clinic | |
| Care Plans for Cancer Predisposition | NCT05736497 | Genetic Predisp... | Digital Care Pl... | 12 Years - | Children's Hospital of Philadelphia | |
| Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) | NCT06340646 | Cholangiocarcin... Multiple Myelom... Colon Cancer Rectal Cancer | Return of Genet... Return of Genet... Return of Genet... | 18 Years - | Washington University School of Medicine | |
| Genetic Testing Decision Aid | NCT05470920 | Epithelial Ovar... Pancreas Adenoc... | Electronic Deci... Pre-Test Geneti... | 18 Years - | Massachusetts General Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
